Rohto Pharmaceutical Co (MEX:4527N) Tariff Resilience Score: 0/10 (As of Jul. 22, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

MEX:4527N Rohto Pharmaceutical Co Ltd MEX:4527N
89 GF Score
Price MXN305.75
GF Value MXN428.89
! 2 Warning Signs
View Full Analysis

What is Rohto Pharmaceutical Co Tariff Resilience Score?

Rohto Pharmaceutical Co has the Tariff Resilience Score of 0, which implies that the company might have .

Rohto Pharmaceutical Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Rohto Pharmaceutical Co might have .

Rohto Pharmaceutical Co  (MEX:4527N) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Rohto Pharmaceutical Co Tariff Resilience Score Related Terms

MEX:4527N
89GF Score
Rohto Pharmaceutical Co Ltd MEX:4527N
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Rohto Pharmaceutical Co (MEX:4527N) Overvalued in 2026?

Based on GuruFocus' analysis, Rohto Pharmaceutical Co stock appears to be undervalued. The current stock price of MXN305.75 is trading 28.7% below its estimated GF Value™ of MXN428.89.

Key valuation signals for MEX:4527N:

  • Tariff Resilience Score: 0
  • GF Value™: MXN428.89 vs. price of MXN305.75 (28.7% below fair value)
  • GF Score™: 89/100 with 2 warning signs

No single metric tells the full story. See the MEX:4527N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rohto Pharmaceutical Co Business Description

Address 1-8-1 Tatsuminishi, Ikuno-ku, Osaka, JPN, 544-8666
Rohto Pharmaceutical Co Ltd is a Japan-based company mainly engaged in the manufacture and sale of health and beauty care products. The company operates through four reportable segments: Japan, America, Europe, and Asia. Each segment manufactures and sells products related to eye care (such as eye drops and eyewash), skin care (including dermatological medications, lip balm, sunscreen, and functional cosmetics), oral medication (such as gastrointestinal and herbal medicines, and supplements), and other products such as in-vitro diagnostic reagents. It generates the majority of its revenue from Japan.
89GF Score

Get the complete analysis for MEX:4527N

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN305.75
Price
MXN428.89
GF Value